BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $3.76 | Prev. Close $3.86 | Circuit Range N/A |
Day Range $3.75 - $3.82 | Year Range $0.61 - $13.78 | Volume 1,108 |
Average Traded $3.78 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $3.76 | $3.76 | -2.08% |
16-Jul-26 | $3.85 | $3.84 | -3.03% |
15-Jul-26 | $3.85 | $3.96 | +7.03% |
14-Jul-26 | $3.75 | $3.70 | -1.33% |
13-Jul-26 | $3.78 | $3.75 | -4.82% |
10-Jul-26 | $3.83 | $3.94 | +7.95% |
09-Jul-26 | $3.82 | $3.65 | -1.88% |
FAQs on BriaCell Therapeutics Corp. Share Price
Can I buy BriaCell Therapeutics Corp. shares in India?
What is the share price of BriaCell Therapeutics Corp.?
What is the 5 year returns of BriaCell Therapeutics Corp.?
What are the high & low stock price of BriaCell Therapeutics Corp. today?
What is the 52-week high and low of BriaCell Therapeutics Corp. stock?